Russia · 
Who invested in IXcellerate?
IXcellerate's investors include Goldman Sachs and Mubadala.
20182019202020212022
$15MBridge$190MSeries CRussia · Series C startup
Who invested in IXcellerate
2 rounds we have observed, with the 2 investors named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.
Funding summaryUpdated 26 Oct 2026
$205Mraised across 2 rounds since 2017, from 2 sources
$15MBridge$190MSeries C
- Latest round
- Series C, $190MJan 2022
- Step-upi
- 12.7×
- Investors
- 2
The funding story
Each circle is a round, placed by date and sized by amount. The line above is the running total.
- First round
- Bridge, $15M Sept 2017
- Biggest round
- $190M Series C · Jan 2022
- Between rounds
- 4.3 years from the last two
The rounds
- Jan 2022
- Sept 2017
Funding filed with regulators
IXcellerate filed 2 raises, $186M in all. Filings say how much was sold and to how many investors; they never name the investors.
- Jan 2022$50MUK share allotment
- Dec 2021$136MUK share allotment
Who was in which round
The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.
Everyone who backed them
Missing a round, or an investor who was in one? Tell us.
Quick answers about IXcellerate
How much has IXcellerate raised?
IXcellerate has raised $205M across 2 rounds since 2017.
When did IXcellerate last raise?
IXcellerate's most recent round was a Series C of $190M in Jan 2022.
What was IXcellerate's biggest round?
Its most recent round, $190M in Jan 2022, is also its largest on record.
Who backed IXcellerate first?
IXcellerate's first round on record, in Sept 2017, was backed by Goldman Sachs.
What stage is IXcellerate at?
IXcellerate's latest named round is a Series C, in Jan 2022.
Where is IXcellerate based?
IXcellerate is based in Russia.
Companies like IXcellerate
In the same sector, and raised in the last eighteen months.
Find investors like these
Search every investor by what they have actually funded, then narrow to your stage and market. Free.